Read publications related to our technologies
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
February 2023
Science
Psychedelic-Inspired Drug Discovery Using an Engineered Biosensor
May 2021
Cell
An Analog of Psychedelics Restores Functional Neural Circuits Disrupted by Unpredictable Stress
May 2021
Molecular Psychiatry
A Non-Hallucinogenic Psychedelic Analog with Therapeutic Potential
January 2021
Nature
Psychedelics Promote Structural and Functional Plasticity
June 2018
Cell Reports
- Frontiers in Psychiatry (2021)
Psychedelics and Other Psychoplastogens for Treating Mental Illness
- ACS Pharmacology & Translational Science (2021)
The Promise of Psychedelic Science
- ACS Pharmacology & Translational Science (2021)
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
- ACS Pharmacology & Translational Science (2020)
Transient Stimulation with Psychoplastogens is Sufficient to Initiate Neuronal Growth
- Journal of Medicinal Chemistry (2020)
Identification of Psychoplastogenic N, N-Dimethylaminoisotryptamine (isoDMT) Analogs Through Structure-Activity Relationship Studies
- ACS Chemical Neuroscience (2019)
Chronic, Intermittent Microdoses of the Psychedelic N, N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
- Journal of Experimental Neuroscience (2018)
Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics